TrademarkDir
EZ SPERSE
LIVE

Serial Number

79187004

Owner

DEXCEL PHARMA TECHNOLOGIES LTD

Attorney

Timothy H. Hiebert

Filing Date

Feb 24, 2016

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EZ SPERSE Trademark

Serial Number: 79187004 • Registration: 5084459

EZ SPERSE is a trademark filed by DEXCEL PHARMA TECHNOLOGIES LTD on February 24, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

DEXCEL PHARMA TECHNOLOGIES LTD (29 trademarks)

Jerusalem 9123901 , IL

Entity Type: 03

Trademark Details

Filing Date

February 24, 2016

Registration Date

November 22, 2016

Published for Opposition

September 6, 2016

Cancellation Date

June 9, 2023

Goods & Services

Orally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, cardiovascular, central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, dermatological, infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, erectile dysfunction, sexual dysfunction, gynecology, obstetric, pediatric, hematologic, oncological, fungal and viral diseases and disorders

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Mar 17, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 26, 2024 INTS
INVALIDATION PROCESSED
Feb 26, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 9, 2024 INTR
CANCELLED SECTION 71
Jun 9, 2023 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 22, 2021 REM3
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Apr 17, 2018 LIMN
LIMITATION OF GOODS RECEIVED FROM IB
Mar 23, 2018 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 1, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 9, 2017 FICS
FINAL DISPOSITION PROCESSED
Mar 9, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 22, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 22, 2016 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 2, 2016 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 6, 2016 NPUB
PUBLISHED FOR OPPOSITION
Sep 6, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 17, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 17, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 17, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 3, 2016 PREV
ASSIGNED TO LIE
Aug 2, 2016 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 22, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 20, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 20, 2016 TROA
REFUSAL PROCESSED BY IB
Jul 9, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 17, 2016 RFCS
REFUSAL PROCESSED BY MPU
Jun 17, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 17, 2016 RFCR
NON-FINAL ACTION WRITTEN
Jun 16, 2016 CNRT
ASSIGNED TO EXAMINER
Jun 9, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
May 31, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 27, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 26, 2016 REPR

Related Trademarks

More from this Owner

M MELTECH logo

M MELTECH

M MELTECH logo

M MELTECH

M MELTECH logo

M MELTECH

DEXCEL PHARMA

DEXCEL PHARMA

DEXCEL PHARMA

DEXCEL PHARMA

DEXCEL PHARMA

DEXCEL PHARMA